6.8 Biological Exposure Indices (BEIs) and Biomonitoring

Biological Exposure Indices (BEIs) and Biomonitoring

Biological monitoring (biomonitoring) is the systematic evaluation of human exposure to chemical agents through the collection and analysis of biological specimens—principally urine, whole blood, serum, or exhaled breath. While personal air monitoring quantifies external airborne exposure, biological monitoring measures the internal effective biological dose, integrating all exposure pathways (inhalation, dermal penetration, and incidental gastrointestinal ingestion), variations in physical workload/ventilation rate, non-occupational exposures, and individual metabolic phenotypes.

---

1. Principles of Biological Monitoring and ACGIH BEIs

   +-------------------------------------------------------------+
   |             AIR MONITORING VS. BIOLOGICAL MONITORING        |
   +-------------------------------------------------------------+
   |                                                             |
   |  PERSONAL AIR SAMPLING          BIOLOGICAL MONITORING       |
   |  - External airborne concentration - Internal effective dose|
   |  - Inhalation route ONLY         - Integrates ALL routes:   |
   |  - Assumes standard breathing      Inhalation, Dermal, GI   |
   |  - Ignores PPE effectiveness     - Accounts for PPE bypass  |
   |  - Ignores worker metabolism     - Captures worker kinetics |
   +-------------------------------------------------------------+

ACGIH Biological Exposure Indices (BEIs)

• A Biological Exposure Index (BEI) is a reference value published by ACGIH representing the concentration of a determinant (parent chemical, metabolite, or reversible biochemical change) in a biological specimen collected from a healthy worker who has been exposed to airborne chemicals at the ACGIH TLV-TWA.
• BEIs are guidelines, not legal mandates (unless adopted into specific OSHA substance standards).
• BEIs do not distinguish between hazardous and non-hazardous exposures in single isolated tests; they indicate whether worker exposure is comparable to that resulting from air concentrations at the TLV.

ACGIH BEI Notations

• 'B' (Background Baseline): The determinant is present in significant detectable quantities in biological specimens of the general public without occupational exposure (e.g., Acetone in urine from endogenous metabolism; Carbon Monoxide in blood from urban air pollution).
• 'Nq' (Non-Quantitative): Biological monitoring is recommended, but quantitative data are insufficient to establish a numerical BEI.
• 'Ns' (Non-Specific): The determinant is non-specific and can arise from other chemical exposures, foods, or common over-the-counter medications (e.g., Hippuric acid in urine from dietary sodium benzoate; t,t-Muconic acid from sorbic acid).
• 'Sq' (Semi-Quantitative): The biological determinant is a marker of exposure but has high analytical or biological variability.

---

2. Specimen Collection Chronobiology & Sampling Timing

The timing of biological specimen collection is determined by the elimination half-life (t(1/2)) of the chemical determinant. Sampling at the wrong physiological timeframe produces completely invalid results.

   +-------------------------------------------------------------+
   |               BEI SPECIMEN COLLECTION CHRONOBIOLOGY         |
   +-------------------------------------------------------------+
   |                                                             |
   |  PRIOR TO SHIFT (16 hr post-exposure)                       |
   |  - Target: Chemicals with intermediate half-lives           |
   |  - Reflects previous days' accumulated exposure             |
   |  - Example: Fluorides in urine                              |
   |                                                             |
   |  END OF SHIFT (Immediately at cessation of work)            |
   |  - Target: Rapidly eliminated metabolites (t1/2 < 5 hr)     |
   |  - Reflects same-day shift exposure                         |
   |  - Example: Acetone, MEK, o-Cresol (Toluene), SPMA (Benzene)|
   |                                                             |
   |  END OF WORKWEEK (After 4-5 consecutive days)               |
   |  - Target: Moderately persistent chemicals (t1/2 15-40 hr)  |
   |  - Reflects cumulative weekly body burden                   |
   |  - Example: Methylhippuric acids (Xylenes), Mandelic (Styr) |
   |                                                             |
   |  DISCRETIONARY / ANY TIME                                   |
   |  - Target: Highly persistent accumulators (t1/2 > months)   |
   |  - Reflects steady-state chronic body burden                |
   |  - Example: Lead in blood, Cadmium in urine/blood           |
   +-------------------------------------------------------------+

Timing Category Details

1. Prior to Shift (16 hours post-exposure):

   • Collected before the worker begins the next work shift, after at least 16 hours without exposure.
   • Eliminates transient acute spikes, measuring persistent body burden accumulated over previous shifts.

2. End of Shift (immediately at work cessation):

   • Collected as soon as possible after the employee finishes the work shift.
   • Ideal for volatile solvents and rapid Phase I/II metabolites (t(1/2) < 5 hours).

3. End of Workweek (after 4 to 5 working days):

   • Collected at the end of the shift on the final day of the workweek (e.g., Friday afternoon).
   • Measures toxicants that accumulate across work shifts due to biological half-lives of 15 to 40 hours.

4. Discretionary / Any Time:

   • Biological determinants with exceedingly long half-lives (t(1/2) > 1 year) achieve stable multi-year steady-state plateaus that do not fluctuate meaningfully across shifts or weeks.

---

3. Major Occupational Biological Monitoring Systems

Comprehensive Summary Table of Critical Industrial BEIs

---

4. Deep Dives: Lead, Carbon Monoxide, and Cholinesterase

Inorganic Lead Biomonitoring: BLL vs. ZPP & Regulatory Mandates

   +-------------------------------------------------------------+
   |                  LEAD BIOMARKER COMPARISON                  |
   +-------------------------------------------------------------+
   |                                                             |
   |  BLOOD LEAD LEVEL (BLL)         ZINC PROTOPORPHYRIN (ZPP)   |
   |  - Gold standard for RECENT     - Gold standard for CHRONIC |
   |    exposure (t1/2 ~ 30 days)      exposure (t1/2 ~ 120 days)|
   |  - Direct circulating metal     - Indirect heme inhibition  |
   |  - Rapidly reflects exposure      (Ferrochelatase block)    |
   |    changes and controls         - Lags BLL shifts by 2-3 mo |
   +-------------------------------------------------------------+

• OSHA Medical Removal Protection (29 CFR 1910.1025 - General Industry):
  • Removal Criteria: Mandatory removal of an employee from lead work if a single blood lead test reaches ≥ 60 µg/dL, or if the average of the last three blood lead tests (or all tests over the previous 6 months) reaches ≥ 50 µg/dL.
  • Return to Work Criteria: Worker may return to former lead work duties only after two consecutive blood lead tests indicate BLL < 40 µg/dL.
  • Medical Removal Protection Benefits (MRPB): Employer must maintain total earnings, seniority, and employment rights for up to 18 months during removal.
• OSHA Construction Standard (29 CFR 1926.62): Mandatory removal at ≥ 50 µg/dL; return at < 40 µg/dL.
• Zinc Protoporphyrin (ZPP): Lead inhibits the mitochondrial enzyme ferrochelatase, which inserts ferrous iron (Fe²⁺) into protoporphyrin IX. Zinc substitutes for iron, producing ZPP. Because ZPP is incorporated into erythrocytes during erythropoiesis, it reflects average exposure over the red cell lifespan (120 days) and lags blood lead changes by 8 to 12 weeks.

Carbon Monoxide Biomonitoring: Coburn-Foster-Kane (CFK) Modeling

• Carboxyhemoglobin (% COHb) in blood is evaluated at the end of the shift against the BEI of 3.5%.
• The mathematical accumulation and clearance of COHb are modeled by the Coburn-Foster-Kane (CFK) equation, which accounts for:
  • Ambient airborne CO concentration (PCO)
  • Alveolar ventilation rate (VA, determined by physical workload)
  • Endogenous CO production rate (VCO)
  • Blood volume and total hemoglobin mass
  • Barometric pressure and ambient oxygen partial pressure (P(O2))
  • Pulmonary capillary diffusion capacity (DL)
• In non-smokers, breathing air at the ACGIH TLV (25 ppm) for 8 hours produces an equilibrium COHb of approximately 3.5%.

Cholinesterase Inhibition: Organophosphates and Carbamates

Organophosphate (OP) and carbamate insecticides inhibit serine esterase enzymes, specifically Acetylcholinesterase (AChE) at neuromuscular junctions and autonomic synapses, causing life-threatening accumulation of acetylcholine (cholinergic toxidrome: SLUDGE — Salivation, Lacrimation, Urination, Defecation, GI distress, Emesis).

   +-------------------------------------------------------------+
   |             RBC AChE VS. PLASMA PSEUDOCHOLINESTERASE        |
   +-------------------------------------------------------------+
   |                                                             |
   |  RBC ACETYLCHOLINESTERASE (AChE)  PLASMA CHOLINESTERASE (BChE)|
   |  - True acetylcholinesterase     - Pseudocholinesterase     |
   |  - Located on erythrocyte membrane - Synthesized by liver   |
   |  - Exact proxy for neural synapse - Highly sensitive, rapid |
   |  - Slow recovery (~1% per day)   - Fast recovery (weeks)    |
   |  - PRIMARY REGULATORY METRIC     - Screening biomarker      |
   +-------------------------------------------------------------+

• Clinical Action Thresholds:
  1. Pre-Exposure Baseline: Must be established before chemical handling begins (average of at least 2 tests taken 3 to 14 days apart).
  2. Exposure Investigation / Re-test: Triggered when RBC AChE or plasma BChE drops ≥ 20% below baseline.
  3. Mandatory Medical Removal: Mandatory removal of the worker from pesticide application duties when RBC AChE depression reaches ≥ 30% below baseline (or plasma BChE drops ≥ 40--50% below baseline in state-mandated programs such as California Cal/OSHA).
  4. Return to Work: Worker may resume pesticide duties when RBC AChE recovers to ≥ 80% of baseline.

---

5. Pre-Analytical Specimen Quality & Normalization

Because hydration status alters urinary dilution, raw spot urine contaminant concentrations (extmg/L or µg/L) can be wildly misleading. ACGIH and clinical toxicology laboratories apply strict pre-analytical validity criteria.

ACGIH Specimen Validity Screening Limits

A spot urine specimen is considered physiologically invalid for BEI determination if:

• Creatinine Concentration: < 0.3 g/L (30 mg/dL, too dilute) OR > 3.0 g/L (300 mg/dL, too concentrated).
• Specific Gravity (SG): < 1.010 (too dilute) OR > 1.030 (too concentrated).

Exam Rule: If a urine sample fails these criteria, the laboratory result cannot be interpreted. Another urine specimen must be collected after normal fluid intake is established.

   +-------------------------------------------------------------+
   |                 URINE SPECIMEN VALIDITY WINDOWS             |
   +-------------------------------------------------------------+
   |  Creatinine:                                                |
   |  [ Invalid: < 0.3 g/L ]  |  ACCEPTABLE: 0.3 to 3.0 g/L  |  [ Invalid: > 3.0 g/L ]
   |                                                             |
   |  Specific Gravity:                                          |
   |  [ Invalid: < 1.010 ]    |  ACCEPTABLE: 1.010 to 1.030  |  [ Invalid: > 1.030 ]
   +-------------------------------------------------------------+

Mathematical Adjustment Formulas

1. Creatinine Normalization

Used for organic metabolites (expressed in µg/g creatinine or mg/g creatinine):

$\mathbf{C_{\text{adj}}\,(\mu\text{g/g creatinine}) = \frac{C_{\text{measured}}\,(\mu\text{g/L})}{\text{Urinary Creatinine}\,(\text{g/L})}}$

2. Specific Gravity Normalization

Used for inorganic metals and electrolytes when creatinine correction is inappropriate, normalizing to standard reference urine specific gravity of 1.024:

$\mathbf{C_{\text{adj}} = C_{\text{measured}} \times \left(\frac{1.024 - 1.000}{\text{SG}_{\text{sample}} - 1.000}\right) = C_{\text{measured}} \times \left(\frac{0.024}{\text{SG}_{\text{sample}} - 1.000}\right)}$

---

6. Worked Step-by-Step Practical Biomonitoring Examples

Worked Example 5.4.1: Urinary Biomarker Specific Gravity Correction

Problem: A boat manufacturing worker laminating fiberglass hulls is monitored for styrene exposure. A spot urine sample collected at the end of the shift contains a measured combined Mandelic acid + Phenylglyoxylic acid concentration (Cmeasured) of 320 mg/L. Refractometer analysis reveals a urine specific gravity (extSG) of 1.012.

1. Check if the urine specimen meets ACGIH validity criteria.
2. Calculate the specific gravity-adjusted biomarker concentration (Cadj) normalized to reference SG = 1.024.
3. Compare the adjusted result to the ACGIH BEI of 400 mg/g creatinine (equivalent to 400 mg/L at standard density).

Solution Steps:

1. Verify specimen validity:

   • SG = 1.012 falls between 1.010 and 1.030 → Valid Specimen.

2. Apply Specific Gravity Adjustment Formula: $C_{\text{adj}} = C_{\text{measured}} \times \left(\frac{1.024 - 1.000}{\text{SG}_{\text{sample}} - 1.000}\right)$ $C_{\text{adj}} = 320\,\text{mg/L} \times \left(\frac{0.024}{1.012 - 1.000}\right) = 320 \times \left(\frac{0.024}{0.012}\right) = 320 \times 2.00 = 640\,\text{mg/L}$

3. Evaluation:

   • Raw uncorrected result (320 mg/L) appeared to comply with the 400 mg/L benchmark.
   • However, because the sample was highly dilute (extSG = 1.012), the standardized concentration is 640 mg/L, revealing a significant biological overexposure exceeding the BEI.

Result: The adjusted concentration is 640 mg/L, demonstrating that dilution correction is essential to avoid false-negative exposure assessments.

---

Worked Example 5.4.2: Creatinine Correction and Specimen Validity Assessment

Problem: End-of-shift urine samples are collected from two chemical operators exposed to benzene vapor (BEI for S-Phenylmercapturic acid [SPMA] = 25.0 µg/g creatinine):

• Operator 1: Measured SPMA = 18.0 µg/L; Measured Creatinine = 1.20 g/L.
• Operator 2: Measured SPMA = 6.0 µg/L; Measured Creatinine = 0.15 g/L.

1. Assess the analytical validity of each specimen under ACGIH rules.
2. For valid specimens, calculate the normalized SPMA concentration in µg/g creatinine and evaluate compliance.

Solution Steps:

1. Validity Screening:

   • Operator 1: Creatinine = 1.20 g/L (0.30 ≤ 1.20 ≤ 3.0 g/L) → Valid Specimen.
   • Operator 2: Creatinine = 0.15 g/L (0.15 < 0.30 g/L, excessively dilute) → INVALID Specimen. Must reject and re-sample.

2. Calculate Creatinine-Normalized Concentration for Operator 1: $\text{SPMA}_{\text{norm}} = \frac{C_{\text{SPMA}}}{\text{Creatinine}} = \frac{18.0\,\mu\text{g/L}}{1.20\,\text{g/L}} = 15.0\,\mu\text{g/g creatinine}$

3. Compliance Evaluation:

   • Operator 1: 15.0 µg/g creatinine ≤ 25.0 µg/g creatinine → Within BEI.

Result: Operator 1's specimen is valid and compliant at 15.0 µg/g creatinine; Operator 2's sample is invalid due to excessive dilution (0.15 g/L creatinine) and must be recollected.

---

Worked Example 5.4.3: Cholinesterase Depression Calculation & Medical Removal Determination

Problem: An agricultural worker applying chlorpyrifos (organophosphate) has pre-exposure baseline cholinesterase tests established prior to spray season:

• Baseline Test 1: RBC AChE = 12.8 IU/g Hb
• Baseline Test 2: RBC AChE = 12.2 IU/g Hb

During mid-season biomonitoring, the worker's RBC AChE is measured at 8.5 IU/g Hb.

1. Calculate the worker's average baseline RBC AChE activity.
2. Calculate the percentage depression of RBC AChE activity from baseline.
3. Determine the required industrial hygiene and medical action.

Solution Steps:

1. Calculate average pre-exposure baseline: $\text{Baseline} = \frac{12.8 + 12.2}{2} = 12.5\,\text{IU/g Hb}$

2. Calculate percentage depression: $\%\,\text{Depression} = \left(\frac{\text{Baseline} - \text{Measured}}{\text{Baseline}}\right) \times 100\%$ $\%\,\text{Depression} = \left(\frac{12.5 - 8.5}{12.5}\right) \times 100\% = \left(\frac{4.0}{12.5}\right) \times 100\% = 32.0\%$

3. Regulatory and Medical Determination:

   • An enzyme depression of 32.0% exceeds the 30% medical removal threshold.
   • Action Required: The worker must be immediately removed from all pesticide handling and application duties.
   • The worker may return to pesticide work only after follow-up testing demonstrates that RBC AChE activity has recovered to ≥ 80% of baseline (12.5 × 0.80 = 10.0 IU/g Hb).

Result: The worker exhibits a 32.0% RBC AChE depression, requiring mandatory medical removal until enzyme levels recover to at least 10.0 IU/g Hb.